A Trial of Adjuvant Chemotherapy in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following Radiotherapy
Clinical trial NCT00370890 · COMPLETED
Trial details
- NCT number
- NCT00370890
- Sponsor
- Chinese University of Hong Kong
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-09-04
- Primary completion
- 2021-10-26
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.